SMARCA4.md
... ...
@@ -25,24 +25,16 @@ timeline
25 25
|Entity|Tier|Description |
26 26
|:------:|:----:|--------------------------|
27 27
|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene|
28
-|![BL](images/icons/BL_tier1.png) |1-EE[@dengSMARCA4HaploinsufficientCell2024] |high-confidence BL gene [@richterRecurrentMutationID32012]|
29
-|![DLBCL](images/icons/DLBCL_tier1.png) |1-EE[@dengSMARCA4HaploinsufficientCell2024] |high-confidence DLBCL gene[@lohrDiscoveryPrioritizationSomatic2012]|
28
+|![BL](images/icons/BL_tier1.png) |1[@dengSMARCA4HaploinsufficientCell2024] |high-confidence BL gene [@richterRecurrentMutationID32012]|
29
+|![DLBCL](images/icons/DLBCL_tier1.png) |1[@dengSMARCA4HaploinsufficientCell2024] |high-confidence DLBCL gene[@lohrDiscoveryPrioritizationSomatic2012]|
30 30
|![FL](images/icons/FL_tier1.png) |1 |high-confidence FL gene [@krysiakRecurrentSomaticMutations2017]|
31 31
|![MCL](images/icons/MCL_tier1.png) |1 |high-confidence MCL gene [@nadeuGenomicEpigenomicInsights2020]|
32 32
33 33
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
34 34
35
-|Entity|source |frequency (%)|
36
-|:------:|:---------------------:|:-------------:|
37
-|BL |GAMBL genomes+capture|22.63 |
38
-|BL |Thomas cohort |17.80 |
39
-|BL |Panea cohort |18.80 |
40
-|DLBCL |GAMBL genomes | 3.25 |
41
-|DLBCL |Schmitz cohort | 2.98 |
42
-|DLBCL |Reddy cohort | 3.30 |
43
-|DLBCL |Chapuy cohort | 2.14 |
44
-|FL |GAMBL genomes | 4.16 |
45
-|MCL |GAMBL genomes | 4.74 |
35
+[[include:DLBCL_SMARCA4.md]]
36
+[[include:FL_SMARCA4.md]]
37
+[[include:BL_SMARCA4.md]]
46 38
47 39
## Mutation pattern and selective pressure estimates
48 40